In OA patients, there is often a background elevation of inflammation characterized by increased secretion of IL-6, IL-8, TNF-α, and MCP-1 cytokines, which might, as a group, contribute to the observed association between OA and COVID-19 (34). This evidence concerns the gene CCL2 and COVID-19.